A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma

Authors :: Preetesh Jain
Onyeka Oriabure
Maria Badillo
Vivian Graham
Michael L. Wang
Hun J. Lee
Hans C. Lee
Rebecca Lu
Lei Feng
Wendy Chen
Robert Z. Orlowski
Elisabet E. Manasanch
Source :: American Journal of Hematology
Publication Year :: 2021
Publisher :: John Wiley & Sons, Inc., 2021.

Subjects :: Oncology
Bendamustine
medicine.medical_specialty
business.industry
Refractory Multiple Myeloma
Hematology
Correspondences
Carfilzomib
chemistry.chemical_compound
Text mining
chemistry
Internal medicine
Correspondence
medicine
business
Dexamethasone
medicine.drug

Tools